Cefoxitine for Injection (2015-04-24)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
| Lot or serial number | Companies | Brand name | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| 0001D4 | - Recalling Firm
- Teva Canada Ltd.
- 30 Novopharm Court,
- Toronto
- M1B 2K9
- Ontario
- CANADA
- Marketing Authorization Holder
- Teva Canada Ltd.
- 30 Novopharm Court,
- Toronto
- M1B 2K9
- Ontario
- CANADA
| B. Cefoxitine for Injection 10 g/vial | Powder for Solution | DIN 02240773 | Cefoxitin (Cefoxitin sodium) 10 g/vial |
| 0001D4 | - Recalling Firm
- Teva Canada Ltd.
- 30 Novopharm Court,
- Toronto
- M1B 2K9
- Ontario
- CANADA
- Marketing Authorization Holder
- Teva Canada Ltd.
- 30 Novopharm Court,
- Toronto
- M1B 2K9
- Ontario
- CANADA
| A. Cefoxitine for Injection 1 g/vial | Powder for Solution | DIN 02128187 | Cefoxitin (Cefoxitin sodium) 1 g/vial |
Recalled Products
A. Cefoxitine for Injection 1 g/vial
B. Cefoxitine for Injection 10 g/vial
Possible presence of dark particles of Active Pharmaceutical Ingredient (API) in the vials, observed only after reconstitution.
Wholesalers, retailers and hospitals
Dear Healthcare Professional Letter: http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2015/53139a-eng.php